Skip to main content
. 2023 Feb 7;28:12. doi: 10.1186/s11658-023-00425-0

Fig. 3.

Fig. 3

Examination of necroptosis-related markers in four groups in vivo. A Immunohistochemistry detected of necroptosis-related markers (RIPK1, RIPK3, and p-MLKL) in each group. B Western blot of necroptosis-related markers (RIPK1, RIPK3, MLKL, p-MLKL, and PGAM5) in each group. CG Relative expression of necroptosis-related markers detected by western blot. *p < 0.05, **p < 0.01, compared with sham group; #p < 0.05, ##p < 0.01, compared with UUO group

HHS Vulnerability Disclosure